Tosoh Bioscience’s Diagnostics Division, part of Tosoh Corporation Japan, is a global leader in diagnostics and liquid chromatography. With representation in over 140 countries and 13,000 employees, Tosoh has established technological excellence in immunochemistry, HPLC-based diabetes and thalassemia screening, and molecular testing solutions. These innovations support the diagnosis and monitoring of diseases such as diabetes, cancer, and infectious disorders.

At WHX Labs Africa, Tosoh presents two highlights:

The AIA®-CL300, a new Automated Chemiluminescent Enzyme Immunoassay Analyzer that sets benchmarks in usability and result precision, contributing to improved patient outcomes.

The G11, Tosoh’s advanced system for accurate and reliable diabetes testing. Renowned for exceptional precision and unique chromatographic separation, it delivers consistent results even in small HbA1c changes, truly reflecting a patient’s condition. Beyond diabetes, the G11 offers high-level expertise in HbA1c and ß-Thalassaemia analysis. Its fully automated workflows combine diagnostic excellence with top productivity, while its proven robustness ensures dependable performance worldwide.Together, Tosoh’s innovations empower laboratories to achieve efficiency, accuracy, and better patient care.